The No. 1 Pharma Stock to Buy in January 2023
While the stock market and the economy have been subdued by progressive interest-rate increases, AbbVie Inc. (ABBV) has not only reported a robust third quarter but also demonstrated its confidence in its long-term prospects by raising its quarterly dividend. Read on…. shutterstock.com – StockNews With the 2% inflation rate targeted by the Federal Reserve still…